80 | GemcitabineFDA Link
01/2022
-
12/2002 |
32 | Cisplatin (Platino)FDA LinkGeneric
01/2022
-
01/2003 |
28 | Sorafenib (BAY 43-9006)FDA Link
01/2021
-
03/2010 |
22 | Pharmaceutical PreparationsIBA
07/2022
-
12/2002 |
19 | Fluorouracil (Carac)FDA LinkGeneric
10/2018
-
02/2002 |
16 | Biomarkers (Surrogate Marker)IBA
06/2022
-
11/2005 |
14 | Proteins (Proteins, Gene)FDA Link
03/2022
-
01/2011 |
12 | Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2019
-
11/2002 |
11 | RamucirumabIBA
06/2020
-
07/2015 |
8 | lenvatinibIBA
09/2022
-
03/2016 |
8 | Alanine Transaminase (SGPT)IBA
06/2017
-
02/2005 |
7 | folfirinoxIBA
08/2022
-
10/2014 |
7 | PlatinumIBA
10/2020
-
04/2004 |
7 | alpha-Fetoproteins (alpha-Fetoprotein)IBA
06/2020
-
01/2006 |
6 | Peptides (Polypeptides)IBA
01/2021
-
12/2009 |
6 | Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2020
-
02/2011 |
6 | BilirubinIBA
10/2019
-
04/2004 |
6 | ProteomeIBA
02/2012
-
11/2005 |
6 | TegafurIBA
03/2011
-
01/2002 |
5 | Antineoplastic Agents (Antineoplastics)IBA
07/2022
-
05/2015 |
5 | Tyrosine Kinase InhibitorsIBA
01/2022
-
02/2011 |
5 | EverolimusFDA Link
11/2021
-
02/2011 |
5 | Protein Subunit VaccinesIBA
01/2021
-
12/2010 |
5 | Monoclonal AntibodiesIBA
01/2021
-
05/2014 |
5 | Epirubicin (Ellence)FDA LinkGeneric
02/2018
-
01/2003 |
5 | DNA (Deoxyribonucleic Acid)IBA
01/2017
-
01/2007 |
5 | EnzymesIBA
11/2015
-
09/2004 |
5 | UracilIBA
03/2011
-
01/2002 |
4 | Biological ProductsIBA
12/2020
-
09/2002 |
4 | Irinotecan (Camptosar)FDA LinkGeneric
10/2018
-
03/2007 |
4 | miriplatinIBA
02/2018
-
04/2004 |
4 | C-Reactive ProteinIBA
01/2016
-
01/2009 |
4 | Ethiodized Oil (Ethiodol)FDA Link
01/2014
-
01/2002 |
4 | S 1 (combination)IBA
01/2013
-
12/2010 |
3 | Serum AlbuminIBA
06/2022
-
11/2002 |
3 | GlypicansIBA
01/2021
-
04/2014 |
3 | Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2021
-
03/2011 |
3 | 130-nm albumin-bound paclitaxelIBA
01/2021
-
10/2018 |
3 | Axitinib (AG 013736)IBA
01/2021
-
03/2011 |
3 | LigandsIBA
01/2021
-
01/2011 |
3 | Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2020
-
01/2018 |
3 | Sunitinib (Sutent)FDA Link
06/2019
-
10/2013 |
3 | Fetal Proteins (Fetoprotein)IBA
01/2019
-
01/2015 |
3 | Immune Checkpoint InhibitorsIBA
01/2019
-
01/2018 |
3 | Streptozocin (Streptozotocin)FDA Link
10/2018
-
07/2015 |
3 | Mitoxantrone (Novantrone)FDA LinkGeneric
06/2017
-
02/2005 |
3 | Hepatitis B Surface Antigens (HBsAg)FDA Link
12/2016
-
09/2012 |
3 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2015
-
03/2011 |
3 | Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
07/2015
-
02/2011 |
3 | (2E,4E,6E,10E)- 3,7,11,15- tetramethyl- 2,4,6,10,14- hexadecapentaenoic acidIBA
06/2015
-
06/2011 |
3 | Transaminases (Aminotransferases)IBA
02/2015
-
01/2005 |
3 | orantinib (SU6668)IBA
10/2014
-
02/2011 |